Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable.” ...

Cantor Fitzgerald reaffirmed its Overweight rating and $170.00 price target on Ascendis Pharma (NASDAQ:ASND) shares, currently trading at $119.49. The firm's analyst highlighted the early adoption of ...

Tuesday, financial research firm Cantor Fitzgerald maintained a Neutral stock rating for Desktop Metal Inc. (NYSE:DM) with a consistent price target of $5.00. The firm's analysts highlighted that ...

Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...

In a report released today, Andres Coello from Scotiabank maintained a Buy rating on AST SpaceMobile (ASTS – Research Report), with a price ...